Tech Company Financing Transactions
Comet Therapeutics Funding Round
Comet Therapeutics, operating out of Cambridge, raised $28.5 million in investment from Canaan Partners, Sofinnova Ventures and BioInnovation.
Transaction Overview
Company Name
Announced On
6/20/2019
Transaction Type
Venture Equity
Amount
$28,500,000
Round
Series A
Investors
Proceeds Purpose
With this funding, we will quickly build out our team and advance the development of the CoMET Platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
CoEnzyme A (CoA) is essential to numerous cellular processes including the metabolism of fatty acids, amino acids and sugars; the regulation of gene expression; and mitochondrial health and the proper functioning of the TCA cycle -- the source of energy all cells need to live.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David de Graaf
Chief Scientific Officer
Art Taveras
Chief Technical Officer
Enej Kuscer
Browse more venture capital transactions:
Prev: 6/20/2019: ValiMail venture capital transaction
Next: 6/20/2019: Realty Mogul venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs